BioPharmX Corp (40) | Business Finance (18)
Browse by Subcategory
Recent Contracts
-
Form of Warrant
(Filed With SEC on November 4, 2021)
-
Underwriting Agreement, dated November 2, 2021 by and between Timber Pharmaceuticals, Inc. and H.C. Wainwright & Co., LLC
(Filed With SEC on November 4, 2021)
-
Form of Restricted Stock Award Agreement
(Filed With SEC on March 23, 2021)
-
Form of Waiver Agreement, dated as of November 19, 2020, by and between Timber Pharmaceuticals, Inc. and the Holders
(Filed With SEC on November 20, 2020)
-
Amended and Restated Registration Rights Agreement, dated July 17, 2020, by and between Timber Pharmaceuticals, Inc. and certain buyers named therein
(Filed With SEC on August 18, 2020)
-
Form of Amendment No. 1 to Securities Purchase Agreement, dated April 27, 2020, by and among Timber, BioPharmX and certain investors parties thereto
(Filed With SEC on April 27, 2020)
-
Form of Exchange Agreement, dated January 28, 2020, between BioPharmX and the Holders
(Filed With SEC on January 29, 2020)
-
Note, dated January 28, 2020, made by BioPharmX in favor of Timber
(Filed With SEC on January 29, 2020)
-
Bridge Loan Credit Agreement, dated January 28, 2020, between BioPharmX and Timber
(Filed With SEC on January 29, 2020)
-
Form of Pre-funded Warrant
(Filed With SEC on November 4, 2021)
-
Form of Restricted Stock Unit Award Agreement
(Filed With SEC on March 23, 2021)
-
Form of Nonqualified Stock Option Grant Agreement
(Filed With SEC on March 23, 2021)
-
Description of Capital Stock
(Filed With SEC on March 23, 2021)
-
Form of B Warrant
(Filed With SEC on June 3, 2020)
-
Form of A Warrant
(Filed With SEC on June 3, 2020)
-
Description of Capital Stock
(Filed With SEC on March 23, 2020)
-
Bridge Warrant To Purchase Common Stock, dated January 28, 2020, made by BioPharmX in favor of Timber
(Filed With SEC on January 29, 2020)
-
Form of Securities Purchase Agreement
(Filed With SEC on March 21, 2019)
